The Inclusion of Race in Prenatal Screening Algorithms

Mary E Norton^{1

2}, Neil Risch^{2

3}

Affiliations

¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, United States.
² Institute of Human Genetics, University of California, San Francisco, San Francisco, CA, United States.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

Editorial

Mary E Norton et al. Clin Chem. 2024.

. 2024 Jul 5;70(7):891-893.

doi: 10.1093/clinchem/hvae073.

Mary E Norton^{1

2}, Neil Risch^{2

3}

¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, United States.
² Institute of Human Genetics, University of California, San Francisco, San Francisco, CA, United States.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.

No abstract available

Comment in

In Reply to Beyond the Screen Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects.
Messerlian G, Palomaki GE. Messerlian G, et al. Clin Chem. 2024 Dec 2;70(12):1496. doi: 10.1093/clinchem/hvae154. Clin Chem. 2024. PMID: 39365157 No abstract available.
Beyond the Screen-Positive Rate: Racial Equity Considerations for Serum Screening for Open Neural Tube Defects.
Pierre CC, Greene DN, Herman DS, Peck Palmer OM, Delaney S. Pierre CC, et al. Clin Chem. 2024 Dec 2;70(12):1494-1495. doi: 10.1093/clinchem/hvae143. Clin Chem. 2024. PMID: 39365173 No abstract available.